TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01464385

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Nutritional Beverage
Description: Nutritional Beverage Oral 237mL

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Beverage
Description: Nutritional Beverage Oral 237 mL

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Beverage
Description: Nutritional Beverage Oral 237mL
Study: NCT03917108

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: retraction cord
Description: retraction cord ( Ultra dent sizes #0, #00, #000 ) is placed in the gingival sulcus using blunt instrument and using cotton roll isolation.

Intervention type: DEVICE
Group type: OTHER
Intervention: subgingival clamp
Description: subgingival clamp (KSK clamps W8A, #44, #42, #43) or (Brinker clamps B5, B6) is placed to retract the gingiva with rubber dam isolation
Study: NCT03045081

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PainTracker Self-Manager
Description: Interactive web-based educational and assessment program supported by a nurse care manager
Study: NCT05060159

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hemofiltration
Description: Postdilutional Hemofiltration
Study: NCT00016146

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GPI-0100

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MUC-2-Globo H-KLH conjugate vaccine
Study: NCT02699554

Intervention type: PROCEDURE
Intervention: Single-event multilevel surgery
Study: NCT03324854

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rives technique
Description: Open ventral hernia repair followed by the placement of the mesh.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rives technique
Description: Open ventral hernia repair followed by the placement of the mesh.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Drainage
Description: Placement of active-close drainage in surgical site.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Drainage
Description: Placement of active-close drainage in surgical site.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylactic
Description: Prophylactic antibiotic 1gm of cefalotin was administered 30 minutes before the incisión.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic
Description: Prophylactic antibiotic 1gm of cefalotin was administered 30 minutes before the incisión.
Study: NCT01484873

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exenatide
Description: Treatment with exenatide 5 mcg twice daily for 4 weeks, then 10 mcg twice daily for 46 weeks.
Study: NCT03012412

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Program for Infertility
Description: The Mindfulness Based Program for Infertility is a manualized group psychological intervention derived from contextual or 3rd wave cognitive-behavioral therapies intended to develop mindfulness and acceptance skills, as well as to promote perceptions of self-efficacy to deal with the demands of an infertility diagnosis and medical treatment. It comprises 10 weekly sessions of approximately 2hr each, run in small groups (ranging from 10 to 13 participants).
Study: NCT03416257

Intervention type: OTHER
Intervention: No intervention

Intervention type: OTHER
Intervention: No intervention
Study: NCT03356951

Intervention type: PROCEDURE
Intervention: TAR through anterior approach and subtalar fusion
Description: Simultaneous total ankle replacement through anterior approach and subtalar fusion

Intervention type: PROCEDURE
Intervention: TAR through lateral approach and subtalar fusion
Description: Simultaneous total ankle replacement through lateral approach and subtalar fusion
Study: NCT01549392

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DECT
Description: DECT at tumor progression and 3 months later

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DECT
Description: DECT at tumor progression and 3 months later

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MR spectroscopy
Description: MR spectroscopy at tumor progression and 3 months later

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MR spectroscopy
Description: MR spectroscopy at tumor progression and 3 months later
Study: NCT05615571

Intervention type: GENETIC
Intervention: Establishment of mitochondrial markers
Description: Establishment of mitochondrial markers from fibroblasts in culture, obtained from a skin biopsy. Establishment of yeast models to show biochemical mitochondrial alterations: introduction of missense variants in the pantothenate kinase yeast gene Cab1 whose deletion is lethal, followed by growth of mutant strains on fermentation and respiratory media.

Intervention type: GENETIC
Intervention: Sequencing tests
Description: sequencing tests of a panel of 22 genes (9 already known and 13 new genes) using a dedicated custom capture and a medium throughput sequencing protocol.
Study: NCT01647282

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: locally-applied minocycline HCl (1 mg)
Study: NCT02570581

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel
Study: NCT02822378

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dried Plum
Description: Participants randomized to the 50g dried plum group will consume 6 dried plums per day for the duration of the 52 week intervention. Participants randomized to the 100g dried plum group will consume 12 dried plums per day for the duration of the 52 week intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dried Plum
Description: Participants randomized to the 50g dried plum group will consume 6 dried plums per day for the duration of the 52 week intervention. Participants randomized to the 100g dried plum group will consume 12 dried plums per day for the duration of the 52 week intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium supplement
Description: All participants will consume calcium supplements for the duration of baseline and intervention.
Study: NCT01647282

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling and root planing (Sc/RP)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scaling and root planing (Sc/RP)
Study: NCT02570581

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril
Study: NCT03009565

Intervention type: OTHER
Intervention: coronary artery disease
Study: NCT01179945

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: benzoate containing test drinks
Description: Subjects will consume 500ml of water with 0.5 grams of sodium benzoate, followed by a solution of 75g sugar in 500ml water with 0.5 grams sodium benzoate 3 hours later.~Each solution will be consumed over 5 minutes.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: non sodium benzoate containing test drinks
Description: Subjects will consume 500ml of water followed by a solution of 75g sugar in 500ml water 3 hours later.~Each solution will be consumed over 5 minutes.
Study: NCT02105428

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training
Description: A progressive increase in duration, frequency and intensity so the last 8 weeks of exercise are performed for 60 min, 5 days per week and at 80% of aerobic capacity. The duration includes a 5 minute warm up and 5 minute cool down. All exercise will be performed on a stationary bicycle (i.e., cycle ergometer).
Study: NCT04256785

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: VSL#3
Description: sachets containing probiotic

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: sachets containing placebo
Study: NCT02570581

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Ramipril

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril
Study: NCT00826020

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omegaven™
Description: 10% Omegaven™, 50 or 100 mL bottle; 1gram/kg/day and is infused over 12-24 hours.
Study: NCT02133027

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rouviere's sulcus
Description: Dissection may be started safely by division of the peritoneum immediately ventral to the sulcus and continued in a triangle bounded by the liver surface, the neck of the gallbladder and the plane of the sulcus.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: surgical instruments
Description: surgical instruments used in the laparoscopic cholecystectomy,such as ratcheted grasper,atraumatic grasper ,scissors.

Intervention type: DEVICE
Group type: OTHER
Intervention: surgical instruments
Description: surgical instruments used in the laparoscopic cholecystectomy,such as ratcheted grasper,atraumatic grasper ,scissors.
Study: NCT00227903

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MI-CBT
Description: Motivationally-enhanced cognitive behavioral skills counseling

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Advice
Description: Advice and education
Study: NCT02822378

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium supplement
Description: All participants will consume calcium supplements for the duration of baseline and intervention.
Study: NCT01533233

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thoracoscopic lobectomy and mediastinal lymph node dissection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thoracoscopic lobectomy and mediastinal lymph node dissection
Study: NCT01541969

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CR Neuromodulation
Description: Ear level device which delivers patterned sound stimulation.~The experimental arm will use the device fitted according to audiologist training given by the manufacturer/funder. An individually specified sound stimulation algorithm is hypothesised to interrupt tinnitus generating activity in the brain. For the first 12 weeks participants will be asked to wear the device every day for 6 hours, and in blocks of time not less than 1 hour. After 12 weeks participants will be unblinded and continue with the same experimental intervention. In weeks 13-36 participants will be asked to wear the device every day for 4 hours, in continuous blocks of at least 1 hour.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tinnitus masking
Description: The active comparator uses the same ear level device and also delivers patterned sound but the stimulus will be determined according to an algorithm predicted not to break up tinnitus generating activity in the brain. It may have a masking effect. For the first 12 weeks participants will be asked to wear the device every day for 6 hours, and in blocks of time not less than 1 hour. After 12 weeks, the participants will be unblinded and the device algorithm will be reprogrammed in the same way as the experimental intervention. In weeks 13-24 participants will be asked to wear the device for 6 hours per day, in continuous blocks of at least 1 hour. In weeks 25-36 they will be asked to continue using the device every day for 4 hours, in continuous blocks of at least 1 hour.
Study: NCT00604331

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pyruvate
Description: sodium pyruvate 300 mmol/L, 360 mL/h i.c. over 30 minutes.
Study: NCT04750720

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sampling by venipuncture (and eventually by nasopharyngeal swab)
Description: Biological samples :~* Serum and plasma from each donor for the purpose of performing (if applicable) the SARS-CoV-2 serologic test~* PBMC (peripheral blood mononuclear cells)~* Nasopharyngeal samples (not mandatory)~Associated data :~* Demographic data~* Description of clinical manifestations related to SARS-CoV-2 infection~* Notion of hospitalization/ambulatory follow-up~Blood Fractioning~* Serum and plasma aliquoted and stored under 250, 500 and 1000 µL (at -80°C)~* Separation of PBMC on Lymphoprep and freezing in liquid nitrogen for subsequent analysis of immune system cells
Study: NCT04743427

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hot pack and exercises
Description: 20-minute hot pack,and three active exercises: (a) chin tucks in supine lying with the head in contact with the floor, (b) active Standing Shoulder pull back , and (c) scapular plane shoulder elevation. (3 sets of 10 repetitions for all the 3 exercises)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hot pack and exercises
Description: 20-minute hot pack,and three active exercises: (a) chin tucks in supine lying with the head in contact with the floor, (b) active Standing Shoulder pull back , and (c) scapular plane shoulder elevation. (3 sets of 10 repetitions for all the 3 exercises)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: body blade(BB)
Description: The Body-blade (Classic, Mad Dogg Athletics, USA), an elastic pole exercise tool with 122 cm in length, 0.68 kg, 4.3 cm in width,based on oscillatory/vibration motions that have been used in training or rehabilitation.The body blade works by rapidly changing directions at a low-frequency rhythm of approximately 4.5 Hz (cycles per second )
Study: NCT00849381

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GSK580299, GSK Biological's HPV vaccine
Description: All subjects will receive 3 doses administered as an intramuscular injection, according to a 0, 1, 6-month schedule.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GSK580299, GSK Biological's HPV vaccine
Description: All subjects will receive 3 doses administered as an intramuscular injection, according to a 0, 1, 6-month schedule.
Study: NCT04599920

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Partial replacement of red meat with legume-based foods
Description: 560 g of cooked and boneless red meat is replaced with legume-based foods providing the equal amount of protein.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Partial replacement of red meat with legume-based foods
Description: 560 g of cooked and boneless red meat is replaced with legume-based foods providing the equal amount of protein.
Study: NCT04237090

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine
Description: Drug identification number : 02369567

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetirizine
Description: Drug identification number : 02231603

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactose pill
Description: Natural product number : 00501190

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium chloride 0.9%
Description: Drug identification number : 00037796
Study: NCT02570581

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril
Study: NCT02947529

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: intravenous dose
Study: NCT02562937

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: text messages related to sedentary behaviour
Description: texts sent twice daily encouraging reduced sedentary behaviour
Study: NCT04987528

Intervention type: DIAGNOSTIC_TEST
Intervention: Aminoterminal type III peptide of procollagen
Description: Serial Measurement of PIIINP in serum and/or BAL

Intervention type: DIAGNOSTIC_TEST
Intervention: Aminoterminal type III peptide of procollagen
Description: Serial Measurement of PIIINP in serum and/or BAL

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung computed tomography
Description: Screening for the presence of reticulation or bronchiectasia within lung parenchyma

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung computed tomography
Description: Screening for the presence of reticulation or bronchiectasia within lung parenchyma
Study: NCT02423005

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurotech Vital Compact
Description: Neuromuscular electrical stimulation of the pelvic floor via an arrangement of external electrodes held in place by a garment.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: itouch Sure Pelvic Floor Exerciser
Description: Vaginal probe with electrodes designed to deliver electrical stimulation to the pelvic floor muscles.
Study: NCT04707820

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ELISPOT
Description: The evolution of the number of gamma interferon (IFN) producing T lymphocytes in response to Spike glycoprotein (Spike glycoprotein) will be assessed by enumeration in ELISPOT method at 4 measurement times: D0 (confirmation of infection by PCR), D+7, D+14 or at hospital departure (D+Departure) and D+56±14 days.~The ELISPOT method consists in stimulating peripheral blood mononuclear cells (isolated by density gradient and containing a known CD3+ T lymphocyte count) over a short period of time (16 to 20 hours) with a pool of 15 amino acid peptides (overlapping on 11 amino acids) representative of the S protein.
Study: NCT03287232

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Vaginal Insert
Description: Daily administration of a placebo vaginal insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasterone 6.5 mg (0.50%) Vaginal Insert
Description: Daily administration of a 6.5 mg (0.50%) prasterone vaginal insert.
Study: NCT03251456

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tertiary care
Description: 1. Inform the parents that there are abnormalities after eye disease screening of their children, and the program of tertiary care for visual developmental disorders~2. The children will be receiving the appropriate therapy in tertiary care and follow-up according to the clinical guidelines~3. Six months after receiving the screening report, all the parents will be interviewed by telephone, or visiting if necessary.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: 1. Inform the parents that there are abnormalities after eye disease screening of their children~2. Inform the parents that they should take their children to the hospital for further consultation~3. Six months after the receiving the screening report, all the parents will be interviewed by telephone, or visiting if necessary.
Study: NCT01262456

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desmopressin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desmopressin

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Desmopressin
Study: NCT02822378

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium supplement
Description: All participants will consume calcium supplements for the duration of baseline and intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Description: All participants will consume vitamin D supplements for the duration of baseline and intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Description: All participants will consume vitamin D supplements for the duration of baseline and intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Description: All participants will consume vitamin D supplements for the duration of baseline and intervention.
Study: NCT01262456

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT02130336

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic interval training

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Continuous moderate-intensity exercise
Study: NCT03209076

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic
Description: Robotic low anterior resection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic
Description: Laparoscopic low anterior resection
Study: NCT03659149

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-333 formulation I
Description: 1 tablet administered before the breakfast(single-dose)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-333 formulation I
Description: 1 tablet administered before the breakfast(single-dose)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-333 formulation I
Description: 1 tablet administered before the breakfast(single-dose)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-333 formulation I
Description: 1 tablet administered before the breakfast(single-dose)
Study: NCT02947529

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: intravenous dose

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: intravenous dose